DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO

dc.contributor.authorInel, TY
dc.contributor.authorKocaer, SB
dc.contributor.authorErez, Y
dc.contributor.authorGulle, S
dc.contributor.authorKarakas, A
dc.contributor.authorAvsar, AK
dc.contributor.authorUslu, S
dc.contributor.authorCan, G
dc.contributor.authorSari, I
dc.contributor.authorBirlik, M
dc.contributor.authorDalkiliç, E
dc.contributor.authorPehlivan, Y
dc.contributor.authorAkar, S
dc.contributor.authorGoker, B
dc.contributor.authorCetin, GY
dc.contributor.authorHaznedaroglu, S
dc.contributor.authorYavuz, S
dc.contributor.authorPirildar, T
dc.contributor.authorDireskeneli, H
dc.contributor.authorAkkoc, N
dc.contributor.authorOnen, F
dc.date.accessioned2025-04-10T10:36:50Z
dc.date.available2025-04-10T10:36:50Z
dc.identifier.e-issn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttp://hdl.handle.net/20.500.14701/42646
dc.language.isoEnglish
dc.titleDO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
dc.typeMeeting Abstract

Files